Sign in to view content

Treatment Burden and Vision Analysis of Anti-VEGF Therapies for the Treatment of Neovascular AMD

Rahul Komati, MD

Video
Published 2020

Related

Predicting Long-term Response to Ranibizumab After Three Injections in Patients With Age-Related Macular Degeneration
Paul Hahn, MD, PhD, FASRS
Annual Meeting Talks
2020
Subfoveal Choroidal Thickness as a Prognostic Factor in Exudative Age related Macular Degeneration.
Jaya B. Kumar, MD, FASRS
On Demand Cases, Courses, and Papers
2017
Number of Injections and Time to Dry Analysis of Brolucizumab Versus Aflibercept in Patients With Neovascular AMD: 96-Week Data From HAWK and HARRIER
Carl D. Regillo, MD
Annual Meeting Talks
2020

Category: AMD-Neovascular

See more